Stevanato Group S.p.A. (STVN): Price and Financial Metrics
GET POWR RATINGS... FREE!
STVN Stock Price Chart Interactive Chart >
STVN Price/Volume Stats
|Current price||$15.90||52-week high||$29.18|
|Prev. close||$15.68||52-week low||$13.35|
|Day high||$15.93||Avg. volume||327,646|
|50-day MA||$15.88||Dividend yield||N/A|
|200-day MA||$19.79||Market Cap||4.70B|
Stevanato Group S.p.A. (STVN) Company Bio
Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.
Most Popular Stories View All
STVN Latest News Stream
|Loading, please wait...|
STVN Latest Social Stream
View Full STVN Social Stream
Latest STVN News From Around the Web
Below are the latest news stories about Stevanato Group SpA that investors may wish to consider to help them evaluate STVN as an investment opportunity.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Q4 & YE 2021 Earnings notification
PIOMBINO DESE, Italy, February 02, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the appointment of Riccardo Butta to the role of President, Americas.
Investment company First Bank & Trust (Current Portfolio) buys Daktronics Inc, Amgen Inc, Bristol-Myers Squibb Co, Realty Income Corp, British American Tobacco PLC, sells Pfizer Inc, Canadian Imperial Bank of Commerce, Cisco Systems Inc, , Electronic Arts Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First Bank & Trust.
PIOMBINO DESE, Italy, January 26, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension to its licensing agreement with Haselmeier, a company of the medmix group, for its Axis-D™ pen injector technology.
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. During the third quarter, the ClearBridge SMID Cap Growth Strategy outperformed the benchmark Russell 2500 Growth Index. On an absolute basis, the Strategy had gains across five of the […]
STVN Price Returns